Russo Rachel M, Schmitt Johan, Gage Christian P, Barratt Jon, Beckett Andrew, Rees Paul, Del Valle Francisco Sánchez, Aries Philippe, Kiriu Nobuaki, Kink Andres
From the Uniformed Services University of the Health Sciences (R.M.R.), Bethesda, Maryland; University of California, Davis (R.M.R., C.P.G.), Sacramento, California; Intensive Care Unit and Anesthesiology Department (J.S.), Military Teaching Hospital Sainte Anne, Toulon, France; Academic Department of Military Emergency Medicine (J.B.), Birmingham, United Kingdom; Royal Canadian Medical Service (A.B.), Toronto, Ontario, Canada; Academic Department of Military Medicine (P.R.), United Kingdom; Hospital of Defense (F.S.D.V.), Madrid, Spain; Intensive Care Unit (P.A.), Military Teaching Hospital Clermont Tonnerre, Brest, France; National Defense Medical College Hospital (N.K.), Namiki, Tokorozawa, Japan; and North Estonia Medical Centre Foundation (A.K.), Tallinn, Estonia.
J Trauma Acute Care Surg. 2025 Aug 1;99(3S Suppl 1):S164-S169. doi: 10.1097/TA.0000000000004683. Epub 2025 Jun 30.
Truncal hemorrhage is a major cause of combat-related mortality, with delayed surgical access likely increasing future fatalities. Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a technique to temporarily control hemorrhage until surgery can be performed. Differences in management, device selection, and training among North Atlantic Treaty Organization (NATO) allies can compromise patient care during deployments. In response, NATO formed a multinational team of REBOA experts to make recommendations for future efforts to standardize care and enhance interoperability. The team held virtual meetings to assess field use, materiel solutions, training programs, and persistent problems. A scoping review was conducted to identify relevant military medicine studies, including those using preclinical combat injury models, guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews framework. Contributions came from published work, gray literature, and expert input. Experts from seven countries participated, identifying 52 key studies, 47 published combat uses, and 14 unpublished cases from Ukraine. Of the multitude of available catheters, only one had recent combat use cases for prolonged partial occlusion, and none were published. Unlike other countries, the United States and the United Kingdom possessed military-specific REBOA guidelines; however, both were outdated and assumed air superiority. Training programs varied significantly, with no standardized approach across NATO. Courses differed in the instructional method, intended audience, content, competencies, and refresher frequency; none included partial REBOA. As such, the Ukrainian military was reliant on training from catheter manufacturers. Arterial access challenges continue to hinder REBOA use. There is a critical need for ongoing data collection from combat to inform best practices. Given the rapid evolution of REBOA devices, the changing landscape of war, and limited published literature on these topics, further NATO research efforts should be applied to develop uniform guidance for REBOA in combat environments.
躯干出血是与战斗相关死亡的主要原因,手术延迟进行可能会增加未来的死亡人数。复苏性血管内主动脉球囊阻断术(REBOA)是一种在手术能够实施之前临时控制出血的技术。北大西洋公约组织(北约)各盟国在管理、设备选择和培训方面存在差异,这可能会在部署期间影响患者护理。作为回应,北约组建了一个由REBOA专家组成的多国团队,为未来规范护理和提高互操作性的工作提出建议。该团队召开了虚拟会议,以评估现场使用情况、物资解决方案、培训计划和持续存在的问题。开展了一项范围综述,以识别相关的军事医学研究,包括那些使用临床前战斗损伤模型的研究,该综述以系统评价和Meta分析扩展版的范围综述框架的首选报告项目为指导。资料来源包括已发表的作品、灰色文献和专家意见。来自七个国家的专家参与其中,确定了52项关键研究、47例已发表的战斗应用案例以及来自乌克兰的14例未发表案例。在众多可用的导管中,只有一种近期有用于延长部分阻断的战斗应用案例,且均未发表。与其他国家不同,美国和英国拥有针对军事用途的REBOA指南;然而,两者都已过时且假定拥有空中优势。培训计划差异很大,北约没有统一的标准方法。课程在教学方法、目标受众、内容、能力要求和复习频率方面各不相同;没有一门课程包括部分REBOA内容。因此,乌克兰军队依赖导管制造商的培训。动脉穿刺挑战继续阻碍REBOA的使用。迫切需要从战斗中持续收集数据,为最佳实践提供依据。鉴于REBOA设备的快速发展、战争形势的变化以及关于这些主题的已发表文献有限,北约应进一步开展研究工作,为战斗环境中的REBOA制定统一指南。